Download Eurofins BioPharma Product Testing Services flyers
Literature
Search >>
- About Us
- Service Models
-
Services
-
BioPharma Product Testing Services
- Quality Control
- Cell Banking
- Process Validation
- Method Development
- Microbiology
- Clinical Trial Support
- Toxicology
- Biosafety Testing
- Custom and cGMP Radiolabeling
- Gene and Cell Therapy
- Category 5, Highly Potent/Toxic Materials Testing
- Regulatory and Quality Consulting Services
- PSS Insourcing Solutions
- Medical Device Testing
- Sterile Fill/Finish Manufacturing
- Human Factors Testing
-
BioPharma Product Testing Services
- Testing Services by Modality
- Locations
- Resources
-
News & Events
- Conferences & Fairs
- Webinars
- Announcements
-
Newsletters
-
Spring 2022
- Westward Ho!
- Viral Safety doubles laboratory footprint
- Sterility Testing Solutions for Every Project Need
- Whitford & Smith advance to new leadership roles in Portage and Columbia
- Major Stability expansion affords greater capacity and service opportunities
- Human Factors MD acquisition
- PSS Celebrates 20th Anniversary
- Pamala Adams
- Transition from R&D Cell Line Development to GMP Bank Manufacture
-
Fall 2022
- Online Ordering to LAWS
- Support next-generation biologics
- EBPT San Diego offers cell based bioassays
- Detection of mycobacterium species in qPCR
- Eurofins BioPharma Product Testing ENCO expands US capabilities footprint
- New Raw Materials Cell Based Services target cell viability and cell potency assays
- Understanding the when, why, and how - Eurofins Human Factors MD
- BioFire® assay
- Micro’s new Bruker MALDI speeds organism identification
- Scott Kingsley
- Spring 2023
-
Fall 2023
- The importance of a robust human factors engineering program
- Eurofins BPT grows Cell & Gene Therapy US Footprint
- Cell and Gene Therapies – When Speed Matters
- TOX and CTM Manufacturing at Eurofins BPT
- Honorable Mention in Sustainable Laboratory Awards
- Helium Usage Management
- Container Closure Integrity Testing needs
- Business in Ethics Award
- Eric Shaver
- Spring 2024
-
Spring 2022
- << Return to BioPharma Services